Diagnostic Performance of Practice Guidelines for Thyroid Nodules: Thyroid Nodule Size versus Biopsy Rates.

Radiology

From the Department of Radiology and Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.M.H.); Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea (J.H.B., C.H.S., S.R.C., Y.J.C., J.H.L.); and Department of Radiology, GangNeung Asan Hospital, University of Ulsan College of Medicine, Seoul, Korea (D.G.N.).

Published: April 2019

Background The diagnostic performance and unnecessary biopsy rates for evaluation of thyroid nodules varies among the current society guidelines. We hypothesized that diagnostic performance and unnecessary biopsy rates of different guidelines are largely determined by different thyroid size thresholds used as cutoff values that determine when to biopsy a thyroid nodule. Purpose To compare the malignancy risk, diagnostic performance, and unnecessary biopsy rates of three guidelines and evaluate the changes according to the nodule size cutoff for biopsy. Materials and Methods This retrospective study included 3323 consecutive thyroid nodules from 3190 patients between January 2013 and December 2013. US features were reviewed according to the American Thyroid Association (ATA), Korean Thyroid Association/Korean Society of Thyroid Radiology (KTA/KSThR), and American College of Radiology (ACR) guidelines. The diagnostic performance and unnecessary biopsy rates were calculated. The size cutoff of ATA and KTA/KSThR guidelines was varied and diagnostic performance and unnecessary biopsy rates were calculated and compared by using the generalized estimating equations method. Results A total of 856 (25.8%) thyroid nodules were diagnosed as malignant after surgical excision or biopsy. The highest sensitivity was observed with the KTA/KSThR guideline (93.5% [300 of 321]), followed by the ATA (92.5% [297 of 321]) and ACR guidelines (60.1% [193 of 321]). The highest specificity (75.2% [1216 of 1617], P < .001) with lowest unnecessary biopsy rate (20.7% [401 of 1938]) was observed with the ACR guideline. When the low-suspicion category in the ATA guideline modeled 2.5 cm instead of 1.5 cm as the size for biopsy, the unnecessary biopsy rate decreased to 43.6% (845 of 1938, 2.5-cm cutoff) compared with 55.1% (1068 of 1938, 1.5-cm cutoff) (P < .001). For the KTA/KSThR guidelines, the unnecessary biopsy rate decreased to 36.4% (706 of 1938, 2.5-cm cutoff) compared with 59.5% (1153 of 1938, 1.5-cm cutoff) (P < .001). Conclusion The diagnostic performance and unnecessary biopsy rates of the American Thyroid Association and the Korean Thyroid Association/Korean Society of Thyroid Radiology guidelines are strongly influenced by nodule size cutoff. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Foley in this issue.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019181723DOI Listing

Publication Analysis

Top Keywords

unnecessary biopsy
36
diagnostic performance
28
biopsy rates
28
performance unnecessary
24
thyroid nodules
16
biopsy
14
thyroid
13
nodule size
12
size cutoff
12
biopsy rate
12

Similar Publications

Background: Hemophagocytic lymphohistiocytosis (HLH) is a non-neoplastic proliferation and macrophage activation that induces cytokine-mediated bone marrow suppression and features of intense phagocytosis in the bone marrow and liver, leading to multi-organ dysfunction and ultimate failure. The diagnosis of HLH in an intensive care setting is challenging, and it is associated with high morbidity and mortality. HLH-94 is the standard protocol for treatment, consisting of dexamethasone and chemotherapy like etoposide.

View Article and Find Full Text PDF

Background: The study evaluated the safety and adequacy of percutaneous transsternal anterior mediastinal core biopsy.

Methods: All percutaneous computed tomography-guided transsternal mediastinal 18-gauge core biopsies performed at 2 academic centers were retrospectively reviewed. Procedural, clinical, and pathology data were recorded.

View Article and Find Full Text PDF

Background: Soft tissue tumors (STTs) in adolescents are relatively rare, and their characteristics and behavior have not been well studied in this age group. The aim of this study was to describe the clinicopathologic patterns of STTs in adolescents aged 10-19 years according to the 2020 WHO classification.

Method: A 10-year retrospective cross-sectional study of 632 surgical samples from adolescents was conducted at a tertiary health facility to determine the frequency, histological patterns and characteristics of STTs in this population.

View Article and Find Full Text PDF

Background: Inadequate treatment responses, chemotherapy resistance, significant heterogeneity, and lengthy treatment durations create an urgent need for new pancreatic cancer therapies. This study aims to investigate the effectiveness of gemcitabine-loaded nanoparticles enclosed in an organo-metallic framework under ketogenic conditions in inhibiting the growth of MIA-PaCa-2 cells.

Methods: Gemcitabine was encapsulated in Metal-organic frameworks (MOFs) and its morphology and size distribution were examined using transmission electron microscopy (TEM) and Dynamic light scattering (DLS) with further characterization including FTIR analysis.

View Article and Find Full Text PDF

Goals: To investigate the effect of obesity on the stages of fibrosis discordance between FibroScan and liver biopsy.

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of liver disease worldwide. Accurate fibrosis assessment is essential in MASLD patients for prognosis and treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!